Your session is about to expire
← Back to Search
Implant-specific treatment for Peri-Implantitis
N/A
Waitlist Available
Led By Georgios Kotsakis, DDS, MS
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 months, 12 months
Awards & highlights
Study Summary
This trial will test whether existing treatments for peri-implantitis are effective in long-term treatment and if not, what new strategies should be designed to address this growing public health concern.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 months, 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 months, 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Titanium elution
Secondary outcome measures
BOP reduction
Bone level changes
Probing depth reduction
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Implant-specific treatmentExperimental Treatment1 Intervention
A cleaning aid that has been specifically designed for implant surface cleaning.
Group II: Tooth-borne treatmentActive Control1 Intervention
A cleaning aid that resembles tooth cleaning instruments and is empirically used for implant surface cleaning.
Find a Location
Who is running the clinical trial?
University of WashingtonLead Sponsor
1,740 Previous Clinical Trials
1,847,636 Total Patients Enrolled
1 Trials studying Peri-Implantitis
34 Patients Enrolled for Peri-Implantitis
Osteogenics BiomedicalIndustry Sponsor
4 Previous Clinical Trials
160 Total Patients Enrolled
1 Trials studying Peri-Implantitis
32 Patients Enrolled for Peri-Implantitis
Georgios Kotsakis, DDS, MSPrincipal InvestigatorAssistant Professor
1 Previous Clinical Trials
34 Total Patients Enrolled
1 Trials studying Peri-Implantitis
34 Patients Enrolled for Peri-Implantitis
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is it presently feasible to enter into this investigation?
"The clinicaltrial.gov listing for this study indicates that patient recruitment is presently suspended; the trial was first posted in November 2017, and last updated on November 9th 2022. In spite of this, 21 other medical trials are still actively seeking enrollees."
Answered by AI
Who else is applying?
What state do they live in?
New York
How old are they?
18 - 65
What site did they apply to?
UTHealth San Antonio
What portion of applicants met pre-screening criteria?
Met criteria
Share this study with friends
Copy Link
Messenger